NewsRoom Articles - Page 677 of 1346

ThursdaySep 05, 2019 11:03 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Ever-Expanding Customer Base for DehydraTECH Drug Delivery Platform

Lexaria Bioscience recently announced its DehydraTECH(TM) patent for pharmaceutical applications of cannabinoids to treat certain disease conditions Lexaria Bioscience’s patented DehydraTECH drug delivery platform can be used to deliver nicotine, cannabinoids and many other useful substances The company has roughly 60 patents pending in countries around the world for its DehydraTECH drug delivery platform Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is at the forefront of the development of useful biotechnology products and has played a pivotal role in developing a way to deliver substances to the brain via non-inhalation methods through the development of a novel drug delivery platform. The…

ThursdaySep 05, 2019 10:23 am

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Building Global Cannabis Company Featuring Premier Plant-Based Health and Wellness Products

Wildflower Brands recently completed its acquisition of City Cannabis Corp. in a deal that includes four operating retail cannabis stores and renovations to additional locations Wildflower holds 14 licenses for cannabis cultivation, manufacturing, distribution and retail in California, the world’s largest cannabis market Expansion plans into Europe’s CBD market are underway via an agreement with Poland-based wellness distribution company Two Towers Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) continues its expansion of retail, online sales and production capacity in both Canada and the United States, building on its strategic goal of becoming a global wellness leader. Its recent acquisition of…

WednesdaySep 04, 2019 1:24 pm

Tinley Beverage Company (CSE: TNY) (OTCQX: TNYBF) Manufacturing Cannabis-Infused Beverages and DSD Services for California Distributors

Pure-play cannabis-infused beverage manufacturer Tinley Beverage Company (CSE: TNY) (OTCQX: TNYBF) recently announced that it has completed the buildout of its permanent bottling facility in Long Beach, California. The company is currently producing its five alcohol-inspired cannabis beverages via a temporary manufacturer, making it one of the only publicly traded companies and the only pure play that now has cannabis beverages in the market. Tinley’s 20,000-square-foot, state-of-the-art-facility is purpose-built for cannabis beverage production, and the company reported that its line is capable of producing at least one million bottles per month, with a space plan for two additional lines that…

WednesdaySep 04, 2019 12:56 pm

VPR Brands LP (VPRB) Positioned to Experience Windfall as Thai Hospitals Start Administering Cannabis Oils

VPR Brands is set to benefit from the approval of medical marijuana in South Asian markets The Thai marijuana industry is expected to reach $661 million by 2024 VPRB announced growth of $1.58 million for Q2 2019, marking a 31 percent increase over last year VPR Brands LP (OTCQB: VPRB), a technology holding company whose assets include issued U.S. and Chinese patents for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components, is positioned to benefit as the Southeast Asian medical market could soon start using medical marijuana for the treatment of its patients. This news…

WednesdaySep 04, 2019 12:23 pm

SRAX Inc. (NASDAQ: SRAX) on Leading Edge of New Data Economy with Proprietary BIGtoken Consumer Data Platform

BIGtoken is the first digital exchange of transparent and verified consumer data, providing subscribers with the ability to own and earn from their own personal data BIGtoken’s diverse global subscriber base is experiencing viral growth, reaching nearly 16 million users by mid-August 2019 SRAX grew its total revenues in Q2 2019 by 53 percent as compared to Q1 2019, and it has officially changed its name as part of its new business strategy SRAX Inc. (NASDAQ: SRAX) is a digital marketing and consumer data management and distribution technology platform company providing marketers, content owners and consumers with the tools to…

WednesdaySep 04, 2019 11:43 am

Neutra Corp. (NTRR) CEO Sydney Jim Discusses Pain Management, CBD Purity and Becoming Vertically Integrated in the Hemp Industry

The company’s CEO discussed NTRR’s strategic acquisition of hemp retail brand Vivis and hemp cultivator J3 Holdings Neutra Corp. plans to finish building and lab improvements to J3 Holdings in 2019 The company’s focus is on CBD as an option to treat types of chronic pain CBD sales in the U.S. are projected to exceed $20 billion by 2024 Texas-based Neutra Corp. (OTCQB: NTRR) is expanding into hemp cultivation and purified hemp extract products. Its CEO, Sydney Jim, discussed the company’s operations and objectives in an exclusive interview with NetworkNewsWire (http://nnw.fm/7wSXR). Jim, a former professional tennis player, emphasized the company’s…

WednesdaySep 04, 2019 11:02 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Rolls Out Online Sales of Discrete Powdered Formulation of CBD-Rich Hemp Oil

Lexaria Bioscience is an innovator in the field of bioavailable lipophilic active compounds, and it is working to make consumption of certain products through oral ingestion a viable alternative to inhalation A particular focus of the company’s technology is to ensure that cannabinoids can enter the blood stream at speeds comparable to smoking and can be used in a discrete manner Cannabis-infused beverage sales are expected to surpass $1.4 billion by 2024, marking a nearly 15-fold increase over 2018 levels Drug bio-delivery technology innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has launched online commercial delivery of the cannabis industry’s…

WednesdaySep 04, 2019 10:25 am

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Builds Multistate Assets Portfolio as US Cannabis Market Heads for $50 Billion

The U.S. cannabis market is racing along at a 25 percent CAGR Nabis Holdings recently issued a letter to shareholders The company has appointed an independent director Based in Vancouver, Canada, Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) is targeting positive cash flow and strategic assets in the cannabis space, both in the United States and abroad. Nabis already has investments in Arizona, California, Michigan and Washington and is looking to expand its portfolio to include four to five more states in the next three to four months. Nabis is headed by two industry veterans who exited another firm after receiving one of…

WednesdaySep 04, 2019 9:00 am

Innovative Drug-Delivery Systems Benefit Patients and Businesses

NetworkNewsWire Editorial Coverage: Drugs play an essential role in treating anything from a mild headache to life-threatening disease — and everything in between. While effectiveness of drugs is what most often captures the spotlight, that effectiveness is closely associated with the drug-delivery technology used, and innovation in this space may have a huge impact on how successful a drug can be. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed one of the most innovative drug-delivery systems seen in years, a system that can be used to deliver a wide range of drugs in a more palatable and…

WednesdaySep 04, 2019 9:00 am

Gene Therapy Treatments Offer Hope for Cancer Patients

NetworkNewsWire Editorial Coverage: Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is focused on using gene therapy to tackle lung cancer, developing new drugs that can be used alongside existing treatments. Pfizer Inc. (NYSE: PFE) has created a state-of-the-art research center focused on gene therapy treatments, which it uses for illnesses including cancer. Gilead Sciences Inc. (NASDAQ: GILD) is using biotechnology to tackle a range of challenging diseases, including HIV and hepatitis. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is developing 20 different…

Financial news and publishing for public and private companies

Contact us: 512.354.7000